REFERENCES
- Pozo D, Delgado M, Martinez M, et al. Immunobiology of vasoactive intestinal peptide (VIP). Immunol Today 2000; 21: 7–11, [PUBMED], [INFOTRIEVE], [CSA]
- Delgado M. VIP: a very important peptide in T helper differentiation. Trends Immunol. 2003; 24: 221–224, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Taylor A W, Streilein J W, Cousins S W. Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. J Immunol. 1994; 153: 1080–1086, [PUBMED], [INFOTRIEVE]
- Ferguson T A, Fletcher S, Herndon J, Griffith T S. Neuropeptides modulate immune deviation induced via the anterior chamber of the eye. J Immunol. 1995; 155: 1746–1756, [PUBMED], [INFOTRIEVE]
- Delgado M, Munoz-Elias E J, Gomariz R P, Ganea D. VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNgamma synthesis by T cells. J Neuroimmunol. 1999; 96: 167–181, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Delgado M, Sun W, Leceta J, Ganea D. VIP and PACAP differentially regulate the costimulatory activity of resting and activated macrophages through the modulation of B7.1 and B7.2 expression. J Immunol. 1999; 163: 4213–4223, [PUBMED], [INFOTRIEVE]
- Delgado M, Abad C, Martinez C, Leceta J, Gomariz R P. Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nat Med. 2001; 7: 563–568, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Caspi R R, Roberge F G, Chan C C, et al. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J Immunol. 1988; 140: 1490–1495, [PUBMED], [INFOTRIEVE]
- Pepperberg D R, Okajima T L, Ripps H, Chader G J, Wiggert B. Functional properties of interphotoreceptor retinoid-binding protein. Photochem Photobiol. 1991; 54: 1057–1060, [PUBMED], [INFOTRIEVE], [CSA]
- Chan C C, Caspi R R, Ni M, et al. Pathology of experimental autoimmune uveoretinitis in mice. J Autoimmun. 1990; 3: 247–255, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Redmond T M, Sanui H, Hu L H, et al. Immune responses to peptides derived from the retinal protein IRBP: immunopathogenic determinants are not necessarily immunodominant. Clin Immunol Immunopathol. 1989; 53: 212–224, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Silver P B, Chan C C, Wiggert B, Caspi R R. The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment. Invest Ophthalmol Vis Sci. 1999; 40: 2898–2905, [PUBMED], [INFOTRIEVE], [CSA]
- Hou W, Wu Y, Sun S, et al. Pertussis toxin enhances Th1 responses by stimulation of dendritic cells. J Immunol. 2003; 170: 1728–1736, [PUBMED], [INFOTRIEVE]
- Kasner L, Chan C C, Whitcup S M, Gery I. The paradoxical effect of tumor necrosis factor alpha (TNF-alpha) in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci. 1993; 34: 2911–2917, [PUBMED], [INFOTRIEVE]
- Silver P B, Agarwal R K, Chan C C, Wiggert B, Caspi R R. Differential roles for IL-12 and TNF-α in pathogenesis of experimental autoimmune uveitis in IFN-γ -deficient and wild type mice. FASEB J. 2001; 15: A355
- Zhang M, Hung L, Gery I. Vasoactive intestinal peptide (VIP) exacerbates endotoxin-induced uveitis (EIU) in mice. Curr Eye Res. 2000; 21: 913–917, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Smith J P, Levinson R D, Holland G N, et al. Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum. 2001; 45: 252–257, [PUBMED], [INFOTRIEVE]